Modulation of Tyrosine Kinase Activity Has Multiple Actions on Insulin Release from the Pancreatic β-Cell: Studies with Lavendustin A

The Japanese Journal of Pharmacology

Mitsuro Hisatomi¹  Tetsuo Hayakawa¹  Hiroyoshi Hidaka²  Ichiro Niki² 

[1]Second Department of Internal Medicine, Nagoya University School of Medicine

[2]Department of Pharmacology, Nagoya University School of Medicine

关键词: Insulin release;    Tyrosine kinase;    Pancreatic β-cell;    Lavendustin A;    yrosine kinase inhibitor;   

DOI  :  10.1254/jjp.74.203

学科分类：药理学

来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society

【 摘 要 】

References(30)Cited-By(5)We investigated the role of tyrosine kinases in the regulation of insulin release from a hamster β-cell line, HIT T15, using selective tyrosine kinase inhibitors. Genistein increased the insulin release induced by glucose, but herbimycin A, tyrphostins and the erbstatin analogue failed to change the release. Lavendustin A at 0.1 nM -1 μM caused a concave-shaped inhibition of the insulin release stimulated by 7 mM glucose. The inhibitory effect of lavendustin A was overcome by higher concentrations of glucose. Lavendustin B, the negative control analogue, had no effect on the release. Lavendustin A at a nanomolar range progressively inhibited insulin release by high K+ (50 mM)-depolarization, whereas the inhibitor did not change the insulin release by Ca2+ ionophore (A23187). On the contrary, lavendustin A at 10 nM significantly increased insulin release when glucose-induced insulin release was enhanced by either 5 μM forskolin or 162 nM 12-Ο-tetradecanoylphorbol 13-acetate. Lavendustin A failed to influence the Ca2+-induced insulin release from HIT cells permeabilized with streptolysin-Ο. These findings suggest that tyrosine kinases may play versatile roles in the control of insulin release from the pancreatic β-cell.

【 授权许可】

Unknown